Active Ingredient: DIFLUNISAL
Proprietary Name: DIFLUNISAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A203547
Product Number: 001
Approval Date: Jun 16, 2017
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information